ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,263.20
      -1.69%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      79.285
      0.00%
      Bitcoin
      94,467.01
      -0.25%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Valbiotis SA (ALVAL) Quote

      Valbiotis SA

      Valbiotis SA (ALVAL)

      EU
      1.598
      0.028
      (1.78%)
      Closed January 11 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.598
      Bid
      1.554
      Ask
      1.618
      Volume
      221,569
      1.524 Day's Range 1.626
      1.07 52 Week Range 4.94
      Market Cap
      25.24M
      Previous Close
      1.57
      Open
      1.568
      Last Trade
      1
      @
      1.598
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      86,332
      Shares Outstanding
      15,794,596
      Dividend Yield
      -
      PE Ratio
      -3.43
      Earnings Per Share (EPS)
      -0.47
      Revenue
      6.81M
      Net Profit
      -7.37M

      About Valbiotis SA

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.valbiotis.com
      Headquarters
      Paris, Paris, Fra
      Founded
      -
      Valbiotis SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALVAL. The last closing price for Valbiotis was 1.57 €. Over the last year, Valbiotis shares have traded in a share price range of 1.07 € to 4.94 €.

      Valbiotis currently has 15,794,596 shares outstanding. The market capitalization of Valbiotis is 24.80 € million. Valbiotis has a price to earnings ratio (PE ratio) of -3.43.

      Ask ADVFN Intelligence (AI)

      ALVAL Latest News

      More News

      Valbiotis meldet durchschlagenden Erfolg der internationalen multizentrischen Phase-II/III-Studie REVERSE-IT zu TOTUM•63: nachgewiesene Wirksamkeit bei Hauptrisikofaktor für Typ-2-Diabetes

      Die Studie erreichte ihr Ziel beim primären Endpunkt, der Senkung des Nüchternblutzuckers – Risikofaktor für Typ-2-Diabetes, bei einer Tagesdosis von 5 g und drei Verabreichungen pro Tag mit...

      May 23 2023
      Business Wire

      Valbiotis Announces the Large Success of the REVERSE-IT International Multicentric Phase II/III Clinical Study on TOTUM•63: Proven Efficacy on the Main Risk Factor of Developing Type 2 Diabetes

      The study achieved its objective on the primary endpoint, the reduction of fasting blood glucose, a risk factor for type 2 diabetes, at a 5g daily dose in 3 intakes per day, with a high...

      May 22 2023
      Business Wire

      Valbiotis – Combined Annual Shareholders General Meeting held on May 2, 2023

      Regulatory News: Valbiotis (FR0013254851 – ALVAL, PEA / SME eligible), a commercially oriented Research and Development company, committed to scientific innovation for preventing and combating...

      May 03 2023
      Business Wire

      Valbiotis annonce la mise à disposition du Document d’Enregistrement Universel

      Regulatory News: Valbiotis (FR0013254851 – ALVAL, éligible PEA / PME) (Paris:ALVAL), entreprise de Recherche et Développement à dimension commerciale, engagée dans l’innovation scientifique, pour...

      April 26 2023
      Business Wire

      Valbiotis annonce la tenue de son Assemblée générale mixte des actionnaires le 2 mai 2023

      Regulatory News: Valbiotis (FR0013254851 – ALVAL, éligible PEA / PME) (Paris:ALVAL), entreprise de Recherche et Développement à dimension commerciale, engagée dans l’innovation scientifique, pour...

      April 14 2023
      Business Wire

      Valbiotis veröffentlicht seine Jahresergebnisse 2022 und gibt ein Update zu seiner strategischen Roadmap

      Eine Barposition von mehr als 20 Millionen Euro zum Ende 2022, die dem Unternehmen finanzielle Visibilität bis zum Ende des ersten Halbjahres 2024 verschafft Ein entscheidendes Jahr an der...

      March 15 2023
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0483.096774193551.551.6261.461068901.53799091DE
      40.27821.06060606061.321.6261.28970921.45631965DE
      120.28821.98473282441.311.6261.15863321.36751024DE
      260.1288.70748299321.471.91.15823981.4251249DE
      52-3.242-66.98347107444.844.941.07826731.92610662DE
      156-5.502-77.49295774657.17.51.07447333.18556101DE
      260-0.782-32.85714285712.388.381.07351473.62099096DE

      ALVAL - Frequently Asked Questions (FAQ)

      What is the current Valbiotis share price?
      The current share price of Valbiotis is 1.598 €
      How many Valbiotis shares are in issue?
      Valbiotis has 15,794,596 shares in issue
      What is the market cap of Valbiotis?
      The market capitalisation of Valbiotis is EUR 24.8M
      What is the 1 year trading range for Valbiotis share price?
      Valbiotis has traded in the range of 1.07 € to 4.94 € during the past year
      What is the PE ratio of Valbiotis?
      The price to earnings ratio of Valbiotis is -3.43
      What is the cash to sales ratio of Valbiotis?
      The cash to sales ratio of Valbiotis is 3.71
      What is the reporting currency for Valbiotis?
      Valbiotis reports financial results in EUR
      What is the latest annual turnover for Valbiotis?
      The latest annual turnover of Valbiotis is EUR 6.81M
      What is the latest annual profit for Valbiotis?
      The latest annual profit of Valbiotis is EUR -7.37M
      What is the registered address of Valbiotis?
      The registered address for Valbiotis is ZI DES QUATRE CHEVALIERS 12F RUE PAUL VATINE, PERIGNY, PARIS, PARIS, 17180
      What is the Valbiotis website address?
      The website address for Valbiotis is www.valbiotis.com
      Which industry sector does Valbiotis operate in?
      Valbiotis operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MLCOTCoretech 5
      0.012 €
      (140.00%)
      		90.21k
      ALCABCabasse SA
      0.72 €
      (41.18%)
      		16.96k
      ALAGOEPango SA
      0.1828 €
      (21.87%)
      		9.37M
      LEBLLcx Leblanc Chr
      0.356 €
      (18.67%)
      		4
      ALALOAcheterLouerFR
      0.11 €
      (15.55%)
      		73.87k
      BNBSTonner Drones
      0.001 €
      (-50.00%)
      		23.99k
      DBVDBV Technologies
      0.875 €
      (-23.91%)
      		4.89M
      MLCOUCourbet
      1.75 €
      (-15.87%)
      		51
      MLAZRThe Azur Selection SA
      1.00 €
      (-15.25%)
      		130.18k
      PROACProactis SA
      0.0565 €
      (-13.74%)
      		560
      ATOAtos SE
      0.002 €
      (0.00%)
      		1.75B
      BCPBanco Comercial Portugues SA
      0.4802 €
      (0.04%)
      		53.25M
      ALCYBCybergun
      0.0001 €
      (0.00%)
      		20.24M
      EDPEDP SA
      2.974 €
      (-4.77%)
      		15.95M
      ALVERVergnet
      0.0018 €
      (0.00%)
      		15.63M

      Discussion

      View Full Feed
      SeaBlue SeaBlue 1 minute ago
      Interesting Boockvar interview. Wow, they covered a lot of topics in 30 minutes. I hope the inflation is in the 3 to 4 percent range he mentioned. I have retirement money tied up and I have it in short-term Treasuries right now so 3 to 4 percent is fine with me. Even if I lose money on the under
      FFMGF
      Polymer Paul Polymer Paul 4 minutes ago
      Belgium's getting rattled... They realise nobody is buying or taking them on board at last. End game 🎯 the Ponzi scheme is over. Time for them to get a real job
      LWLG
      WeTheMarket WeTheMarket 8 minutes ago
      EVgo Receives First Drawdown from $1.25 Billion Loan Guarantee
      January 8, 2025
      https://investors.evgo.com/news/news-details/2025/EVgo-Receives-First-Drawdown-from-1.25-Billion-Loan-Guarantee/default.aspx

      $75 million drawdown will support deployment of convenient, reliabl
      EVGO
      sab63090 sab63090 10 minutes ago
      boi568

      I saw a message from you in my email alert about Jill Biden and my message was not other than to alert to her presence at the conference and the noticeable alertness of her husband so I mentioned she might be addressing Alzheimer's...no political slant. It's gone on the iHub no
      AVXL
      Golden Cross Golden Cross 12 minutes ago
      $ILLR Triller Is More Than Just An App.
      Watch Below⬇️
      https://youtube.com/watch?v=jHqdI9vhjaw

      [yt]jHqdI9vhjaw[/yt]
      ILLR
      Golden Cross Golden Cross 14 minutes ago
      $ILLR Triller Is More Than Just An App.
      Watch Below⬇️
      https://youtube.com/watch?v=jHqdI9vhjaw

      [yt]jHqdI9vhjaw[/yt]
      ILLR
      diggitydoodle diggitydoodle 15 minutes ago
      The trolls on this forum must meet in a tree fort to memorize and coordinate their turns of saying the exact same lame schtick...but at different pre determined times. All adding up to a well tuned troll machine. 🤣🤣🤣🤣🤣
      Start a troll union, I'm sure clow
      RNVA
      fishhunter fishhunter 16 minutes ago
      Why can’t VirTra issue a PR right now that lays out expectations for 2025 revenue, eps, and FCF? These guys remain pathetic.
      VTSI
      More Belgians More Belgians 17 minutes ago
      OK, I will remember, you don't have to listen to me :-)
      As far as your second question....I don't get frustrated when investing...I'm more rational than that....

      And when it comes to frustration.....re-read your own posts.........
      Clearly venting here doesn't help you
      LWLG
      sab63090 sab63090 17 minutes ago
      Steady T
      The hedge funds work with the mm's to provide a short term push up allowing them to scale up into their short positions and accumulate a line...notice how the price advance also includes retail excitement in accomplishing this....so the volume is not super high but high enough to aff
      AVXL
      trunkmonk trunkmonk 17 minutes ago
      XRP is the 1984 Apple of the financial worlds eye for tomorrow.
      BTC is the 800lb gorilla, just like IBM was, and became the defacto way out of the Covid lockdowns. IBM lead the way and was virtually the only way back then
      https://youtu.be/ErwS24cBZPc?si=lZH2jOxF6ajop-By
      I luv th
      XRPUSD
      Reefrad Reefrad 17 minutes ago
      You are 100% wrong. Better exit your short position this week. The clock is ticking.
      NWBO
      GoonOfWallSt GoonOfWallSt 18 minutes ago
      Wen reverse split and revocation?
      CRKN
      GoonOfWallSt GoonOfWallSt 19 minutes ago
      What a pile of garbage junk sh!t scam
      THBD
      waterpro42 waterpro42 19 minutes ago
      Great job bigt most here appreciate your efforts the rest is noise
      RSPI
      jimr1717 jimr1717 20 minutes ago
      New Tesla Involved in a Crash While on FSD, the Teslacam Footage Was All Police Needed
      3 Nov 2024, 22:00 UTC •

      Bob claims that the moment the pickup truck slammed into his rear end, the FSD turned the steering wheel to the left to prevent his Tesla from hitting the vehicle wait
      TSLA
      flipper44 flipper44 21 minutes ago
      Edit:

      JMHO And as I’ve discussed before, there appears to be pathways to NHS-CDF before a NICE appraisal process completes .
      NWBO
      The Penny Preacher The Penny Preacher 22 minutes ago
      I have been trying to get people on this forum to call the man since June of '23.

      TPP
      navycmdr navycmdr 23 minutes ago
      Recapitalizing the GSEs through Administrative Action: Economics and Budgetary Implications

      Link to Register: https://events.urban.org/RecapitalizingtheGSEs

      register for this virtual event

      Date & Time

      Tuesday, January 14, 2025
      FNMA
      LTListener LTListener 24 minutes ago
      Good to hear and thanks for the information.

      Comprehensive and potential milestones/activities (i.e. "many other things") is what investors are starving for. Couple that with some funding and a plan to emerge to a liquid market and this will begin to correct all faults. It is certai
      RSPI
      trunkmonk trunkmonk 26 minutes ago
      Mr. Calabria understood and understands Federal Statutes, the man helped write HERA. As FHFA Director Mr. Calabria knew he did not need Treasury’s permission to pay down the Senior Preferred Stock. He knew about the illegal commitment fee attached to the SPS. He wrote about it. Apparently he didn’t
      FNMA
      StayHumble StayHumble 27 minutes ago
      💹💹💹 Perfect Time to BUY💹 Xperts Buying Lots💹💹 huzzah
      HIRU

      Your Recent History

      EU
      ALVAL
      Valbiotis
      EU
      ASNO
      ASN Beleggingsfondsen Ai...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads